Tirzepatide, the ingredient in Zepbound, is sold only as a once-weekly injection
Patients typically experience reductions in appetite, increased fullness after meals, less craving for high-calorie foods, and improved energy levels
Recent studies have also demonstrated that exendin-4 is mediated by Ca 2+ /calmodulin (CaM)-dependent protein kinase kinase/CAM-dependent protein kinase IV/prolactin regulatory element binding (CaMKK/CaMKIV/PREB) pathway increases liver ABCA1 expression and reduces cholesterol accumulation [71]
Understanding how GLP-1 medications affect overall well-being can help normalize the adjustment experience and reduce anxiety about the process itself
GIP receptor agonism provides insulin sensitization in adipose tissue, enhanced nutrient-stimulated insulin secretion (complementing the GLP-1 component), potential direct CNS effects on appetite regulation, and improved adipose tissue lipid handling and metabolism